- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers (2022) 14:3, 778. https://doi.org/10.3390/cancers14030778
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2023
- Urheber
-
Esnault, Clara
Schrama, David
Houben, Roland
Guyétant, Serge
Desgranges, Audrey
Martin, Camille
Berthon, Patricia
Viaud-Massuard, Marie-Claude
Touzé, Antoine
Kervarrec, Thibault
Samimi, Mahtab
- DOI
-
10.3390/cancers14030778
- URN
-
urn:nbn:de:bvb:20-opus-262192
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Esnault, Clara
- Schrama, David
- Houben, Roland
- Guyétant, Serge
- Desgranges, Audrey
- Martin, Camille
- Berthon, Patricia
- Viaud-Massuard, Marie-Claude
- Touzé, Antoine
- Kervarrec, Thibault
- Samimi, Mahtab
- Universität Würzburg
Entstanden
- 2023
Ähnliche Objekte (12)
Peptide-drug conjugates for advanced targeted cancer therapy
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Oligosaccharides based antibacterial drug conjugates
Development and characterization of anti-EGFR protein-drug conjugates for tumor therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Oligosaccharides based antibacterial drug conjugates
Development and characterization of anti-EGFR protein-drug conjugates for tumor therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Oligosaccharides based antibacterial drug conjugates